Autoimmune & Arthritis

CAR T Cells and Bispecific Antibodies Aim to Reset Immunity in Rheumatoid Arthritis

Could rheumatoid arthritis treatment move beyond lifelong medication? This review examines two emerging approaches that remove B cells involved in harmful immune responses: engineered immune cells called CAR T cells and antibodies that help other immune cells attack B cells. Instead of continually suppressing inflammation, these treatments aim to reshape the immune system. Early clinical evidence suggests that some patients may achieve lasting remission without medication. However, the abstract does not report patient numbers, success rates, comparison groups, or how long patients were followed. The findings therefore support further investigation, not a proven cure or a reason to stop existing treatment. The authors call for better trials and long-term safety monitoring. For patients whose disease remains active despite several treatments, these approaches represent a research direction worth discussing with a rheumatologist.